Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of effectiveness and safety of Subolesin anti-tick vaccine in Ugandan multi-site field trial.
Kabi F, Contreras M, Semakula J, Sánchez-Sánchez M, Muñoz-Hernández C, Mugerwa S, Kasaija P, Kirunda H, de la Fuente G, Fernández-Melgar R, Rafael M, Fernández de Mera IG, Matovu M, Kyakuwa I, Dhikusooka M, Nsereko G, Boma P, Bugeza J, Moses M, Namukasa A, Obonyo P, Ssekabunga N, Adyero OE, Rutaisire J, Gortazar C, de la Fuente J. Kabi F, et al. Among authors: kyakuwa i. NPJ Vaccines. 2024 Sep 18;9(1):174. doi: 10.1038/s41541-024-00966-1. NPJ Vaccines. 2024. PMID: 39294184 Free PMC article.
Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection.
Kerfua SD, Haydon DT, Wilsden G, Ludi A, King DP, Okurut RA, Atim S, Dhikusooka MT, Kyakuwa I, Motta P, Paton DJ. Kerfua SD, et al. Among authors: kyakuwa i. Vaccine. 2024 Sep 12;42(26):126325. doi: 10.1016/j.vaccine.2024.126325. Online ahead of print. Vaccine. 2024. PMID: 39270355 Free article.
Corrigendum to "Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection" [Vaccine 42 (1-12) (2024) 126325].
Kerfua SD, Haydon DT, Wilsden G, Ludi A, King DP, Okurut RA, Atim S, Dhikusooka MT, Kyakuwa I, Motta P, Paton DJ. Kerfua SD, et al. Among authors: kyakuwa i. Vaccine. 2024 Nov 5;43(Pt 1):126480. doi: 10.1016/j.vaccine.2024.126480. Online ahead of print. Vaccine. 2024. PMID: 39504856 Free article. No abstract available.